Details for New Drug Application (NDA): 204442
✉ Email this page to a colleague
The generic ingredient in PROBUPHINE is buprenorphine hydrochloride. There are twenty-nine drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the buprenorphine hydrochloride profile page.
Summary for 204442
Tradename: | PROBUPHINE |
Applicant: | Titan Pharms |
Ingredient: | buprenorphine hydrochloride |
Patents: | 1 |
Formulation / Manufacturing: | see details |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | IMPLANT;IMPLANTATION | Strength | EQ 80MG BASE/IMPLANT | ||||
Approval Date: | May 26, 2016 | TE: | RLD: | Yes | |||||
Patent: | ⤷ Try a Trial | Patent Expiration: | Apr 25, 2024 | Product Flag? | Substance Flag? | Delist Request? | |||
Patented Use: | FOR OPIOID DEPENDENCE |
Complete Access Available with Subscription